Back to Search Start Over

Thiazide diuretics and the risk for hip fracture

Authors :
Klift, M. (Marjolein) van der
Laet, C.E.D. (Chris) de
Herings, R.M.C. (Ron)
Stijnen, Th. (Theo)
Pols, H.A.P. (Huib)
Stricker, B.H.Ch. (Bruno)
Schoofs, M.W.C.J. (Marlette)
Hofman, A. (Albert)
Klift, M. (Marjolein) van der
Laet, C.E.D. (Chris) de
Herings, R.M.C. (Ron)
Stijnen, Th. (Theo)
Pols, H.A.P. (Huib)
Stricker, B.H.Ch. (Bruno)
Schoofs, M.W.C.J. (Marlette)
Hofman, A. (Albert)
Publication Year :
2003

Abstract

BACKGROUND: Since most hip fractures are related to osteoporosis, treating accelerated bone loss can be an important strategy to prevent hip fractures. Thiazides have been associated with reduced age-related bone loss by decreasing urinary calcium excretion. OBJECTIVE: To examine the association between dose and duration of thiazide diuretic use and the risk for hip fracture and to study the consequences of discontinuing use. DESIGN: Prospective population-based cohort study. SETTING: The Rotterdam Study. PARTICIPANTS: 7891 individuals 55 years of age and older. MEASUREMENTS: Hip fractures were reported by the general practitioners and verified by trained research assistants. Details of all dispensed drugs were available on a day-to-day basis. Exposure to thiazides was divided into 7 mutually exclusive categories: never use, current use for 1 to 42 days, current use for 43 to 365 days, current use for more than 365 days, discontinuation of use since 1 to 60 days, discontinuation of use since 61

Details

Database :
OAIster
Notes :
application/pdf, Annals of Internal Medicine, English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn929962440
Document Type :
Electronic Resource